Radial artery vs saphenous vein graft used as the second conduit for surgical myocardial revascularization: long-term clinical follow-up

Journal of Cardiothoracic Surgery

Petar Otasevic¹  Bosko Djukanovic¹  Nebojsa Tasic¹  Dragana Kosevic¹  Olivera Djokic¹  Predrag Milojevic¹  Miodrag Peric¹  Dusko Nezic¹  Ivana Petrovic¹ 

[1] Dedinje Cardiovascular Institute and Belgrade University School of Medicine, Belgrade, Serbia

关键词: Clinical outcome;    Saphenous vein graft;    Radial artery graft;   

Others  :  1230554
DOI  :  10.1186/s13019-015-0331-9

 received in 2015-01-01, accepted in 2015-10-05,  发布年份 2015

【 摘 要 】

Background

There is ongoing debate regarding the efficacy of the radial artery (RA) as an aortocoronary conduit, with few solid data regarding long-term clinical results. We sought to determine if the use of the RA as the second arterial conduit, beside left internal thoracic artery (LITA), would improve long-term clinical outcome after CABG as compared to saphenous vein graft (SVG).

Methods

Between March 2001 and November 2003, 200 patients underwent isolated CABG and were randomized in 1:1 fashion to receive either LITA and RA grafts or LITA and SVGs. The primary end point was composite of cardiovascular mortality, non-fatal myocardial infarction and need for repeat myocardial revascularization (either surgical or percutaneous).

Results

There was no significant difference in absolute survival, with 12 deaths in each group during the study period (log rank = 0.01, p = 0.979). There were 3 and 2 cardiac deaths in RA and SVG groups, respectively. There was no difference in long-term clinical outcome between the groups (log rank = 0.450, p = 0.509). Eleven patients in RA group had one or more non-fatal events; 7 patients suffered a myocardial infarction, 9 patients underwent percutaneous coronary angioplasty, and 1 patient required redo coronary surgery. Likewise, 13 patients in SVG group had non-fatal event; 7 patients had myocardial infarction, 13 patients had percutaneous coronary intervention and 3 patients required redo coronary surgery. Angiograms were performed in 23 patients in RA group (patency rate 92 %) and 24 in SVG group (patency rate 86 %) (p = 0.67).

Conclusion

In this small randomised study our data indicate that there is no difference in the 8 year clinical outcomes in relatively young patients between those having a RA or a saphenous vein graft used as a second conduit, beside LITA, for surgical myocardial revascularisation.

【 授权许可】

   
2015 Petrovic et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Loop F, Lytle B, Cosgrove D, Steward RW, Goormastic M, Williams GW et al.. Influence of the internal mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986; 314:1-6.
• [2]Carpentier A, Guermonprez JL, Deloche A, Frechette C, DuBost C. The aorta‐to‐coronary radial artery bypass graft. A technique avoiding pathological changes in grafts. Ann Thorac Surg. 1973; 2:111-21.
• [3]Slaughter MS. Conduits for surgical arterial revascularization: the answer is…. Circulation. 2011; 124:1313-4.
• [4]Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting. Ann Thorac Surg. 2009; 87:19-26.
• [5]Tranbaugh RF, Dimitrova KR, Friedmann P, Geller CM, Harris LJ, Stelzer P et al.. Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention. Circulation. 2012; 126(11 Suppl 1):S170-5.
• [6]Dimitrova KM, Hoffman DM, Geller CM, Dienstag B, Cohen BC, Tranbaugh RF. Patency of endoscopically harvested radial artery grafts. Innovations. 2010; 5:265-9.
• [7]Goldman S, Sethi GK, Holman W, Thai H, McFalls E, Ward HB et al.. Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery. JAMA. 2011; 305:167-74.
• [8]Collins P, Webb CM, Chong CF, Moat NE. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008; 117:2859-64.
• [9]Desai ND, Cohen EA, Naylor CD, Fremes SE. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004; 351:2302-9.
• [10]Tatoulis J, Buxton BF, Fuller JA, Meswani M, Theodore S, Power N et al.. Long-term patency of 1108 radial-coronary angiograms over 10 years. Ann Thorac Surg. 2009; 88:23-30.
• [11]Buxton BF, Raman JS, Ruejgsakulrach P, Gordon I, Rosalion A, Bellomo R et al.. Radial artery patency and clinical outcomes: five year interim results of a randomized trial. J Thorac Cardiovasc Surg. 2003; 125:1363-71.
• [12]Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004; 109:2086-91.
• [13]Nasso G, Coppola R, Bonifazi R, Piancone F, Bossetti G, Speziale G. Arterial revascularization in primary coronary artery bypass grafting: direct comparison of 4 strategies: results of the stand-in-Y mammary study. J Thorac Cardiovasc Surg. 2009; 137:1093-100.
• [14]Athanasiou T, Saso S, Rao C. Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition—which conduit offers better patency? A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2011;40:208–20.
• [15]Tranbaugh RF, Dimitrova KR, Friedmann P. Radial artery conduits improve long-term survival after coronary artery bypass grafting. Ann Thorac Surg. 2010; 90:1165-72.
• [16]Possati G, Gaudino M, Prati F, Alessandrini F, Trani C, Glieca F et al.. Long-term results of the radial artery used for myocardial revascularisation. Circulation. 2003; 108:1350-4.
• [17]Desai ND, Naylor CD, Kiss A, Cohen EA, Feder-Elituv R, Miwa S et al.. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Circulation. 2007; 115:684-91.
• [18]Alexander JH, Emery RW, Carrier M. MEND-CABG II Investigators Efficacy and safety of pyridoxal 5′-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA. 2008; 299:1777-87.
• [19]Mentzer RM, Bartels C, Bolli R. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg. 2008; 85:1261-70.
• [20]Yau JM, Alexander JH, Hafley G. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). Am J Cardiol. 2008; 102:546-51.
• [21]Locker C, Schaff HV, Derani JA, Joyce LD, Park SJ, Burkhart M et al.. Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease. Circulation. 2012; 126:1023-30.
• [22]Hayward PA, Gordon IR, Hare DL, Matalanis G, Horrigan ML, Rosalion A et al.. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. J Thorac Cardiovasc Surg. 2010; 139:60-7.
• [23]Ruttmann E, Fischler N, Sakic A, Chevtchik O, Alber H, Schistek R et al.. Second internal thoracic artery versus radial artery in coronary artery bypass grafting: a long-term, propensity score-matched follow-up study. Circulation. 2011; 124:1321-9.
• [24]Achouh P, Isselmou KO, Boutekadjirt R, D’Alessandro C, Pagyny JY, Fouquet R et al.. Reappraisal of a 20‐year experience with the radial artery as a conduit for coronary bypass grafting. Eur J Cardiothorac Surg. 2012; 41:87-92.
• [25]Gaudino M, Possati G, Alessandrini F, Luciani N, Glieca F, Trani C et al.. Midterm clinical and angiographic results of radial artery grafts used for myocardial revascularization. J Thorac Cardiovasc Surg. 1998; 116:1015-21.
• [26]Butns DJ, Swinamer SA, Fox SA, Romsa J, Vezina W, Akcinioglu C et al.. Long term patency of endoscopically harvested radial arteries from a randomized controlled trial. Innovations. 2015; 10:77-84.